Detection of p16 promoter methylation in the serum of oral cancer patients

Int J Oral Maxillofac Surg. 2006 Apr;35(4):362-5. doi: 10.1016/j.ijom.2005.08.005. Epub 2005 Nov 18.

Abstract

P16 promoter methylation occurs frequently in oral squamous cell carcinoma (OSCC). For the early detection of tumour-related aberrant DNA, we examined p16 methylation using the methylation-specific polymerase chain reaction (MSP) in tumour and serum samples of 17 OSCC patients. Aberrant p16 methylation was detected in 11 (64.7%) cases of primary OSCC. Of these 11 patients, 6 (54.5%) showed the same alteration in their serum. No methylation was found in control groups. Interestingly, DNA was detected in the serum of 3 out of 4 patients with recurrence. These results suggest that the MSP may be a sensitive and useful method for detecting recurrent OSCC.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / blood
  • Carcinoma, Squamous Cell / genetics*
  • DNA Methylation*
  • Female
  • Genes, p16*
  • Humans
  • Male
  • Middle Aged
  • Mouth Neoplasms / blood
  • Mouth Neoplasms / genetics*
  • Neoplasm Recurrence, Local / genetics*
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic